Skip to content

Insulin Lispro

Published: July 26, 2026Updated: July 26, 2026

Insulin Lispro is a rapid-acting insulin analog that begins working within 15 minutes of injection, making it ideal for improving blood sugar control in adults and children with diabetes mellitus.

Quick summary

Insulin Lispro is a rapid-acting insulin used to control blood sugar in people with diabetes.

Medically reviewed by WellAlly Editorial TeamLast reviewed July 26, 2026Editorial policy

Key facts at a glance

ATC
A10AB04
RxNorm
86009
Generic
Insulin Lispro
Class
atc-a10
Brands
Humalog, Admelog, Lyumjev, Humalog Mix
Availability
rx
Lactation
unknown
Routes
—
Forms
solution, suspension
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Dosage and administration

adult (standard)subcutaneous injection
Usual dose
individualized based on blood glucose monitoring and carbohydrate intake
Maximum
consult physician
Frequency
administered within 15 minutes before or after meals
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
pediatric (standard)subcutaneous injection
Usual dose
individualized based on blood glucose monitoring, carbohydrate intake, and body weight
Maximum
consult physician
Frequency
administered within 15 minutes before or after meals
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
geriatric (standard)subcutaneous injection
Usual dose
individualized with careful monitoring to avoid hypoglycemia; typically lower doses initially
Maximum
consult physician
Frequency
administered within 15 minutes before or after meals
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard

Overdose information

Important overdose information
Toxic dose: Dose highly variable based on individual insulin sensitivity; doses far exceeding prescribed amounts can cause severe hypoglycemia
Chronic overdose: Repeated excessive dosing leads to recurrent hypoglycemia and potential neurological damage
Immediate actions
Administer oral glucose if conscious; administer intravenous dextrose if unconscious or unable to swallow; monitor blood glucose continuously
Antidote
Dextrose (glucose)(Immediate glucose administration is critical and potentially life-saving)
Poison Control: 1-800-222-1222

Special Populations

8 groups
⚠

pregnancy

first trimester
caution
FDA Category
B
Dose Adjustment

individualize dose based on blood glucose monitoring

Key Recommendations

insulin is preferred treatment for diabetes in pregnancy; continue use if already established or initiate if benefits outweigh risks

Monitor

frequent blood glucose monitoring, HbA1c every trimester, fetal growth monitoring

Use with caution and monitor for adverse effects.

⚠

pregnancy

second trimester
caution
FDA Category
B
Dose Adjustment

typically requires increased insulin doses due to insulin resistance

Key Recommendations

continue insulin lispro with close monitoring; insulin requirements typically increase

Monitor

regular blood glucose monitoring, fetal growth assessments

Use with caution and monitor for adverse effects.

⚠

pregnancy

third trimester
caution
FDA Category
B
Dose Adjustment

may require further dose increases; adjust based on monitoring

Key Recommendations

maintain tight glycemic control to reduce risk of preterm delivery and preeclampsia

Monitor

frequent monitoring, non-stress tests, biophysical profiles as indicated

Use with caution and monitor for adverse effects.

✓

lactation

postpartum
safe
FDA Category
B
Dose Adjustment

may require dose reduction postpartum

Key Recommendations

insulin lispro is compatible with breastfeeding; monitor maternal glucose levels

Monitor

monitor maternal blood glucose and infant feeding patterns

✓

pediatric_age

children 3 18 years
safe
FDA Category
B
Dose Adjustment

individualize dosing based on weight, diet, and activity; start low and titrate

Key Recommendations

approved for use in pediatric patients age 3 years and older with diabetes

Monitor

frequent blood glucose monitoring, regular HbA1c checks, growth monitoring in younger children

⚠

geriatric

elderly 65 years and older
caution
FDA Category
B
Dose Adjustment

start with lower doses, use conservative titration due to increased hypoglycemia risk

Key Recommendations

use with caution due to increased risk of hypoglycemia unawareness and renal impairment

Monitor

frequent blood glucose monitoring, renal function monitoring

Use with caution and monitor for adverse effects.

⚠

renal_impairment

mild to moderate renal impairment
caution
FDA Category
B
Dose Adjustment

dose reduction may be necessary; monitor closely for hypoglycemia

Key Recommendations

insulin clearance may be reduced; adjust dose based on blood glucose monitoring

Monitor

frequent blood glucose monitoring, periodic renal function assessment

Use with caution and monitor for adverse effects.

⚠

hepatic_impairment

mild to moderate hepatic impairment
caution
FDA Category
B
Dose Adjustment

may require dose adjustment due to altered glucose metabolism and insulin clearance

Key Recommendations

use with caution; hepatic dysfunction may affect gluconeogenesis and insulin requirements

Monitor

frequent blood glucose monitoring, liver function tests

Use with caution and monitor for adverse effects.

Statistics and clinical data

prescribingFDA
2023

FDA approval year

Value:1996

Initial FDA approval date for Insulin Lispro

drug_classWHO
2023

Drug class

Value:Rapid-acting insulin analog

Pharmacological classification of Insulin Lispro

mechanismFDA
2023

Mechanism of action

Value:Binds to insulin receptors to facilitate cellular glucose uptake

Primary pharmacological mechanism

pharmacokineticsFDA
2023

Onset of action

Value:10-15 minutes

Time to beginning of insulin action after subcutaneous administration

Treatment of type 1 and type 2 diabetes mellitus in adults and children to improve glycemic control. Typically administered at mealtimes to manage postprandial blood glucose levels.

Insulin Lispro binds to insulin receptors on cells, stimulating glucose uptake into skeletal muscle and adipose tissue while suppressing hepatic glucose production. This dual action lowers blood glucose levels and mimics the body's natural rapid insulin response to meals.

Must be administered via subcutaneous injection shortly before or after meals. Requires regular blood glucose monitoring. Hypoglycemia is the most common adverse effect. Should not be used during episodes of hypoglycemia or in patients with hypersensitivity to insulin lispro or any excipients.

Contraindications

Conditions and patient states where this medication should be avoided or used with caution.

Do not use (1)

ABSOLUTEhypersensitivity

Known allergy to this medication or its components

Use caution (1)

RELATIVEpregnancy

Consult healthcare provider for benefits vs risks assessment

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed July 26, 2026. · Read our editorial policy